PARP-1 inhibition to treat cancer, ischemia, inflammation
- 31 July 2005
- journal article
- editorial
- Published by Elsevier in Pharmacological Research
- Vol. 52 (1) , 1-4
- https://doi.org/10.1016/j.phrs.2005.02.007
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Nicotinamide mononucleotide activation of a new DNA-dependent polyadenylic acid synthesizing nuclear enzymePublished by Elsevier ,2004
- NAD+-Dependent Modulation of Chromatin Structure and Transcription by Nucleosome Binding Properties of PARP-1Cell, 2004
- Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361JNCI Journal of the National Cancer Institute, 2004
- Chromatin Loosening by Poly(ADP)-Ribose Polymerase (PARP) at Drosophila Puff LociScience, 2003
- Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.Genes & Development, 1995
- Inhibitors of poly (ADP-ribose) polymerase suppress lipopolysaccharide-induced nitrite formation in macrophagesBiochemical and Biophysical Research Communications, 1991
- Poly(ADP-ribose) polymerase inhibitors preserve oxidized nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesisBiochemistry, 1983
- Inhibitors of poly(adenosine diphosphate ribose) polymerase induce sister chromatid exchangesBiochemical and Biophysical Research Communications, 1980
- The Enhancement of Cytotoxicity of N‐Methyl‐N‐nitrosourea and of y‐Radiation by Inhibitors of Poly(ADP‐ribose) PolymeraseEuropean Journal of Biochemistry, 1980
- Structure of poly(adenosine diphosphate ribose): identification of 2'-[1''-ribosyl-2''-(or 3''-)(1'''-ribosyl)]adenosine-5',5'',5'''-tris(phosphate) as a branch linkage.Proceedings of the National Academy of Sciences, 1979